Pharmacokinetic, Immunogenicity, and Safety Evaluation of Pegfilgrastim TPI-120 in Healthy Adults

Clinical trial NCT07416955 · COMPLETED

Trial details

NCT number: NCT07416955
Sponsor: Kashiv BioSciences, LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteer

Start date: 2025-04-05
Primary completion: 2025-10-10
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.